Efficacy, Safety and Tolerability of Simvastatin in Children with Familial Hypercholesterolaemia: Rationale, Design and Baseline Characteristics

By Dejongh S.  

Clinical Drug Investigation, Vol. 22, Iss. 8, 2002-08 ,pp. : 533-540

Adis International

Access to resources Recommend Favorite

Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin in Subclinical Atherosclerosis—The Rationale and Methodology of the METEOR Study

By Crouse III John Robert   Grobbee Diederick E.   O'Leary Daniel H.   Bots Michiel L.   Evans Gregory W.   Palmer Mike K.   Riley Ward A.   Raichlen Joel S.    

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 3, 2004-05 ,pp. : 231-238

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study

By Athyros V.G.  

Clinical Drug Investigation, Vol. 16, Iss. 3, 1998-09 ,pp. : 219-227

Adis International

Access to resources Recommend Favorite

Benefits and Risks of Simvastatin in Patients with Familial Hypercholesterolaemia

By Mata P.  

Drug Safety, Vol. 26, Iss. 11, 2003-01 ,pp. : 769-786

Adis International

Access to resources Recommend Favorite

Self-Reported Adherence to Cholesterol-Lowering Medication in Patients with Familial Hypercholesterolaemia: The Role of Illness Perceptions

By Senior Victoria   Marteau Theresa   Weinman John  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 6, 2004-11 ,pp. : 475-481

Springer Publishing Company

Access to resources Recommend Favorite